Erbitux

Details

---

Cetuximab 100mg, 500mg Injection is an Anticancer agent. It binds to Epidermal Growth Factor Receptor (EGFR protein) in some tumors. It is a manmade monoclonal antibody. Worldwide, it is also available by the name of Erbitux.

Purpose:

Cetuximab 100mg, 500mg Injection is used in:

• Combination with radiation therapy for the initial treatment of regionally or locally advanced squamous cell carcinoma of the head and neck.
• Combination with platinum-based therapy with fluorouracil for the first-line treatment of patients with metastatic squamous cell carcinoma of the head and neck, and recurrent locoregional disease.
• Treatment of patients with metastatic or recurrent squamous cell carcinoma of the head and neck for whom prior platinum-based therapy was not effective.

 

Mechanism:

Erbitux slows or stops the growth of cancer cells. It binds to receptors on cancer cells thus destroying the cancer cells from the immune system of the body.

 

Dosage:

• Strictly as prescribed by your doctor.
• It should only be injected via a vein.
• To lessen the side effects of Cetuximab 100mg, 500mg Injection, diphenhydramine may be given.
• The initial dose should be 400 mg one week prior to radiation therapy.
• The subsequent dosage should be 250 mg.

 

Side effects:

• Common side effects of Erbitux tablets are weight loss, vomiting, nausea, dry skin, hair loss, mouth sores, loss of appetite, tiredness, changes in taste, or voice.
• It is indicated to increase your blood pressure.
• If you experience any signs of constipation, overactive thyroid, slow heartbeat, unusual weight loss, or cold intolerance, visit your doctor right away, before the situation worsens.
• Other side effects include fainting, bloody stools, swelling, trouble in breathing, back pain, changes in vision, unusual pain, jaw pain, muscle spasms, dark urine, yellowing of the skin, sore throat, easy bruising among others.
• Gastrointestinal perforation
• Drug-induced hepatitis
• Hemorrhage
• Cardiac ischemia
• WT interval prolongation

 

Precautions and measures:

• Keep a regular check on your blood pressure while you’re on medication for these tablets.
• If you have had a medical history of coronary artery disease, high blood pressure, aneurysm, break in the aorta, liver disease, heart attack, or any recent injury, inform your doctor.
• It may cause low levels of magnesium and potassium in the blood.
• Erbitux can result in delayed healing of wounds.
• If you’re planning to have surgery, during the tenure of this drug, discuss the risks and benefits with your doctor.
• Pregnant women are advised not to consume these tablets as it is absorbed through lungs and skin and can harm the unborn baby.

Breastfeeding is not recommended during the tenure of Cetuximab 100mg, 500mg Injection and for 2 weeks after discontinuing the drug.

Frequently Asked Questions

1. What is Erbitux?
Erbitux is an anti-cancer medicine containing cetuximab, a monoclonal antibody and epidermal growth factor receptor (EGFR) antagonist. It is administered by intravenous infusion under the supervision of qualified healthcare professionals.

2. What is Erbitux used for?
Erbitux is used in the treatment of certain head and neck cancers and metastatic colorectal cancer. For colorectal cancer, patient selection may depend on specific molecular characteristics such as RAS status and, in certain treatment settings, BRAF V600E mutation status.

3. How does Erbitux work?
Erbitux works by targeting and blocking the EGFR pathway, which can play an important role in the growth and survival of certain cancer cells. By interfering with EGFR signaling, cetuximab can help inhibit cancer-cell growth in appropriate patients.

4. How is Erbitux administered?
Erbitux is administered as an intravenous infusion. The dosage and infusion schedule depend on the cancer being treated, the treatment regimen and the patient’s clinical condition. Treatment should only be administered according to the prescribing oncologist’s instructions.

5. What are the common side effects of Erbitux?
Common adverse reactions may include skin reactions such as rash, itching and nail changes, headache, diarrhea and infections. Other reactions may occur depending on the treatment combination. Patients should be monitored by healthcare professionals during treatment.